Home » Stocks » Enochian Biosciences

Enochian Biosciences, Inc. (ENOB)

Stock Price: $3.36 USD 0.06 (1.82%)
Updated Oct 23, 2020 4:00 PM EDT - Market closed

Stock Price Chart

Key Info

Market Cap 156.70M
Revenue (ttm) n/a
Net Income (ttm) -11.42M
Shares Out 46.64M
EPS (ttm) -0.25
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a

Stock Quote

Trading Day Oct 23, 2020
Last Price $3.36
Previous Close $3.30
Change ($) 0.06
Change (%) 1.82%
Day's Open 3.30
Day's Range 3.30 - 3.50
Day's Volume 28,232
52-Week Range 1.95 - 13.43

More Stats

Market Cap 156.70M
Enterprise Value 155.59M
Earnings Date (est) n/a
Ex-Dividend Date n/a
Shares Outstanding 46.64M
Float 3.81M
EPS (basic) -0.25
EPS (diluted) -0.25
FCF / Share -0.22
Dividend n/a
Dividend Yield n/a
Earnings Yield n/a
FCF Yield n/a
Payout Ratio n/a
Shares Short 1.06M
Short Ratio 8.61
Short % of Float 27.87%
Beta 0.43
PE Ratio n/a
Forward PE n/a
P/FCF Ratio n/a
PS Ratio n/a
PB Ratio 0.94
Revenue n/a
Operating Income -11.92M
Net Income -11.42M
Free Cash Flow -10.27M
Net Cash 1.11M
Net Cash / Share 0.02
Gross Margin n/a
Operating Margin n/a
Profit Margin n/a
FCF Margin n/a
ROA -4.16%
ROE -6.73%
ROIC -171.50%
Stats based on trailing-twelve-month (ttm) numbers.

Analyst Summary

Analyst Ratings (0)

Buy 0
Overweight 0
Hold 0
Underweight 0
Sell 0

Analyst Consensus: n/a

Price Target

$n/a*
*No analysts have provided price targets for this stock.

Financial Performance

Financial numbers in millions USD.

Financial Overview

Year2020201920182017
Revenue----
Operating Income-11.92-10.99-5.33-2.40
Net Income-11.42-18.02-6.31-2.14
Shares Outstanding46.3337.5521.9412.27
Earnings Per Share-0.25-0.48-0.29-0.17
Operating Cash Flow-10.46-8.51-4.34-1.18
Capital Expenditures0.18-0.72-0.03-
Free Cash Flow-10.27-9.22-4.37-1.18
Cash & Equivalents8.7012.2815.603.94
Total Debt7.58--2.09
Net Cash / Debt1.1112.2815.601.85
Assets1781801834.52
Liabilities11.836.7823.762.99
Book Value1661731591.53
Numbers in millions USD, except per-share numbers.

Company Profile

Company Details

Full Name Enochian Biosciences, Inc.
Country United States
Employees 10

Stock Information

Ticker Symbol ENOB
Stock Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Unique Identifier NASDAQ: ENOB

Description

Enochian Biosciences, a pre-clinical stage biotechnology company, focuses on development of human therapeutics for infectious diseases and cancers. The company's lead candidate include ENOB-HV-01 for autologous HIV curative treatment. Its pipeline development products consist of ENOB-HV-11, a preventive HIV vaccine; and ENOB-HV-12, a therapeutic HIV vaccine. The company's pipeline development products also include ENOB-HB-01, a coopting Hepatitis B polymerase; ENOB-DC-01, an off-the-shelf DC vaccine pulsed with MCV lysate; ENOB-DC-11 innovative DC vaccine for multiple solid tumors; and ENOB-DC-21, a non-specific vaccine for intratumoral injection. The company has strategic partnerships with The Scripps Institute, Fred Hutchinson Cancer Center, and The Hepatitis B Foundation and Baruch S. Blumberg Institute. Enochian Biosciences, Inc. is headquartered in Los Angeles, California.